Assessment of Automatic Tourniquets for Soldiers During Wartime
Launched by MEDICAL CORPS, ISRAEL DEFENSE FORCE · Nov 6, 2023
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness and ease of use of automatic tourniquets (AUT) compared to standard mechanical tourniquets (CAT) for controlling bleeding in healthy adults. The main focus is to find out if AUTs can stop blood flow as well as CATs and if they are easy to use for soldiers in active or reserve service. Participants will be asked to apply both types of tourniquets on their arms and legs, and researchers will check how well each tourniquet works and how simple it is to use them.
To be eligible for this trial, participants must be soldiers currently serving or in reserve. However, individuals with certain conditions like muscle or nerve disorders, skin diseases on their limbs, recent limb surgeries, rickets, or high blood pressure cannot participate. If you join the study, you can expect to try out both tourniquets and provide feedback on your experience. This information will help determine if automatic tourniquets could be a good option for managing severe bleeding in military situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Soldier in active service or active reserve service.
- Exclusion Criteria:
- • Muscle disorders
- • Peripheral nerve disorders
- • Skin diseases of the limbs
- • Limb surgery in the past
- • Rickets
- • Hypertension
About Medical Corps, Israel Defense Force
The Medical Corps of the Israel Defense Forces (IDF) is a leading entity in military medicine, dedicated to advancing healthcare standards and medical research within the armed forces. Committed to enhancing the health and well-being of soldiers and civilians alike, the Medical Corps engages in innovative clinical trials aimed at improving medical practices and treatments. By leveraging cutting-edge research methodologies and a diverse patient population, the IDF Medical Corps seeks to contribute significantly to the fields of trauma care, emergency medicine, and public health, while ensuring the highest ethical standards in all clinical endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ramat Gan, , Israel
Patients applied
Trial Officials
Tomer Erlich, MD
Principal Investigator
Head of Medical innovation and R&D
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported